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background: Each month the endometrium becomes inﬂamed, and the luminal portion is shed during menstruation. The subsequent
repair is remarkable, allowing implantation to occur if fertilization takes place. Aberrations in menstrual physiology can lead to common gynae-
cological conditions, such as heavy or prolonged bleeding. Increased knowledge of the processes involved in menstrual physiology may also have
translational beneﬁts at other tissue sites.
methods: Pubmed and Cochrane databases were searched for all original and review articles published in English until April 2015. Search
terms included ‘endometrium’, ‘menstruation’, ‘endometrial repair’, ‘endometrial regeneration’ ‘angiogenesis’, ‘inﬂammation’ and ‘heavy men-
strual bleeding’ or ‘menorrhagia’.
results: Menstruation occurs naturally in very few species. Human menstruation is thought to occur as a consequence of preimplantation
decidualization, conferring embryo selectivity and the ability to adapt to optimize function. We highlight how current and future study of endo-
metrial inﬂammation, vascular changes and repair/regeneration will allow us to identify new therapeutic targets for common gynaecological dis-
orders. In addition, we describe how increased knowledge of this endometrial physiology will havemany translational applications at other tissue
sites.Wehighlight the clinical applications ofwhatweknow, the key questions that remain and the scientiﬁc andmedical possibilities for the future.
conclusions: The study of menstruation, in both normal and abnormal scenarios, is essential for the production of novel, acceptable
medical treatments for common gynaecological complaints. Furthermore, collaboration and communication with specialists in other ﬁelds
could signiﬁcantly advance the therapeutic potential of this dynamic tissue.
Key words: endometrium / inﬂammation / angiogenesis / progesterone / hypoxia
Introduction
Thephenomenon of humanmenstruation has been shrouded inmystery
throughout history. Many questions regarding menstrual physiology
remain unanswered, not least ‘why does it happen?’ Historically, men-
struation has been regarded negatively. Historia Naturalis states ‘Wine
sours if they pass, vines wither, grass dies, and buds are blasted.
Should a menstruating woman sit under a tree, the fruit will fall. A
looking glass will discolour at her glance, and a knife turn blunt’ (Pliny,
AD 77–79). Aristotle viewed menstruation as an outward sign of
female inferiority, a view that persisted into the nineteenth century and
beyond. A leading British psychiatrist in 1874 wrote ‘with one week of
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the month more or less sick and unﬁt for hard work she is intellectually
handicapped’. A pioneering nineteenth century Scottish gynaecologist
claimed, ‘young girls should not play music or read serious books
because it makesmuchmischief with theirmenstrual cycle’. Hencemen-
struation was regarded as incapacitating and, in turn, intellect dangerous
for menstrual physiology.
These negative connotations of menstruation are inextricably linked
to the lower social position of women in society. Currently, global differ-
ences inwomen’s rights and status have a dramatic impact on reproduct-
ive health and consequently their morbidity and mortality. As women
receive high quality education, begin working outside the home, gain
the right to vote and have easy access to emergency healthcare and
birth control, the ‘taboo’ of menstruation weakens. Therefore, some
see the attitude of a society to menstruation as a barometer for civiliza-
tion and equality. When in the USA in the 1960s, it was suggested that
women lacked the ability to hold positions of responsibility and power
due to their menstrual cycle, eminent US endocrinologist Estelle
Ramage counteracted, ‘In man, the shedding of blood is always asso-
ciated with injury, disease, or death. Only the female half of humanity
is seen to have themagical ability to bleed profusely and still rise phoenix-
like each month from the gore’. Despite this positive outlook, historical
negative connotations of menstruation still have a signiﬁcant impact in
current society, including the perceptions and expectations of women
and their healthcare providers.
However, aswomenundertakepositionsof responsibility in thework-
place and home, abnormal menstruation can cause signiﬁcant socio-
economic problems. Abnormal menstrual bleeding affects 20–30% of
premenopausal women (RCOG, 2011), and more than 800 000
women seek treatment annually in the UK (NICE, 2007). A US study
demonstrated ﬁnancial losses of .$2000 per patient each year due to
work absence andhomemanagement costs (Frick et al., 2009).Although
time has proven that physiologicalmenstruation is not a barrier to female
success; family and career responsibilities may become impossible if
heavy or painful bleeding occurs. Due to advances in family planning,
women in developed countries now can expect greater than 400 epi-
sodes of menstruation in their lifetime. This is in stark contrast to our
ancestors and women in very underdeveloped countries, who have
40 menstrual bleeds due to multiple pregnancy and long spells of lac-
tational amenorrhoea (Short, 1976). In thisway,menstrual abnormalities
are a relatively modern disorder.
As societies’ view ofmenstruation changes for the better, the views of
individual women suffering from common menstrual problems remain
understandably negative.This reviewarticle aims toprovide scientiﬁc evi-
denceof both facets ofmenstrual physiology. First, hownormalmenstru-
ation could contribute to scientiﬁc and clinical breakthroughs in all areas
of health anddiseaseandconversely, howaberrations inmenstrual physi-
ology can result in signiﬁcant reproductive disorderswith a severe impact
on quality of life (Fig. 1). As we detail the physiology of menstruation, we
aim to highlight the clinical applications of what we know, the key ques-
tions that remain and the scientiﬁc andmedical possibilities for the future.
Methods
Pubmed and Cochrane databases were searched for all original and review
articles published in English until April 2015. Search terms included ‘endo-
metrium’, ‘menstruation’, ‘endometrial repair’, ‘endometrial regeneration’
‘angiogenesis’, ‘decidualization’, ‘inﬂammation’, ‘heavy menstrual bleeding
(HMB)’ and ‘menorrhagia’. We reviewed the manuscripts and included
them as appropriate.
Results
To bleed or not to bleed?
Human females areoneof the few species thatmenstruate, alongside old
world primates, elephant shrews and fruit bats. The ovarian steroid
Figure1 The relevance ofmenstrual physiology. The perimenstrual endometrium (centre) is exposed to inﬂammation and hypoxia. Stem cells and EMT
are involved atmenses to enable scar-free repair (light blue). Aberrations in these processes can lead to gynaecological disorders (mid-blue). Studyof endo-
metrial physiology may help delineate the pathogenesis of a number of disorders in other tissue sites (dark blue).
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hormones regulateendometrial function andhumanmenstruation.After
humanovulation, the corpus luteum secretes high levels of progesterone
to maintain endometrial receptivity should fertilization occur. In the
absence of pregnancy the corpus luteum regresses, causing a sharp
decline in circulating progesterone levels. This triggers a local inﬂamma-
tory response in the endometrium involving inﬁltration of leukocytes,
cytokine release, oedema and activation of matrix metalloproteinases
(Jabbour et al., 2006). The result is tissue breakdown and shedding of
the upper two-thirds of the endometrium (the functional layer) during
the menstrual phase of the cycle (see ‘What causes menstruation’
section). However, in non-menstruating species tissue breakdown and
bleeding do not occur in response to progesterone withdrawal.
Instead of shedding, considerable remodelling and reabsorption of the
endometrium takes place.
Many theories for why women menstruate have been proposed, in-
cluding defence against pathogens contained in sperm or energy efﬁ-
ciency of shedding versus endometrial maintenance. However, these
theories do not account for differences between menstruating and non-
menstruating mammals or the evolutionary basis of menstruation (Finn,
1996). Current evidence favours the spontaneous decidualization hy-
pothesis. During the secretory phase (post ovulation until menstruation)
of themenstrual cycle progesterone acts upon an estrogenprimedendo-
metrium. This causes decidualization; converting the elongated endo-
metrial stromal cells into more spherical decidual cells and increasing
their production of prolactin, insulin-like growth factor binding
protein-1 (IGBP-1) and glycogen (Brosens et al., 1999; Dunn et al.,
2003).Decidualization is initiatedby cAMPandoccurs in theperivascular
stromal cells before spreading in an outward ‘wave’ across the stromal
compartment. In women, and indeed all of the menstruating species,
decidualization occurs ‘spontaneously’ prior to implantation. In contrast,
the endometrium of non-menstruating mammals only undergoes decid-
ualizationwhen there is contact between the embryo and endometrium,
i.e. at the time of implantation (Finn, 1998).
There is a strong correlation between the degree of trophoblast inva-
sion during placental development and the extent of decidualization
(Finn, 1996). Of note, the human endometrium undergoes the most ex-
tensive decidualization process and demonstrates the greatest degree of
trophoblast invasion of all species (Ramsey et al., 1976). This extensive
and spontaneous decidualization reaction is thought to confer maternal
immunotolerance to the partially allogenic embryo, allowing controlled
placental invasion (Emeraet al., 2012). In addition, spontaneousdecidua-
lizationmayprovide amaternal screen for genetically abnormal embryos.
Many human pre-implantation embryos contain genetic aneuploidies
and chromosomal imbalances, similar to those found in cancer cells. It
seems prudent that the maternal environment should provide some se-
lection over the embryos thatwill invade the endometrium. This hypoth-
esis is supported by ﬁndings inwomenwith recurrentmiscarriage,where
a higher proportion of poor quality embryos implant into a suboptimally
decidualizedendometrium (Salkeret al., 2012). Therefore,menstruation
is obligatory in the absence of pregnancy, as spontaneous decidualization
of the endometrium has taken place. Thismay be viewed as an inevitable
consequenceof reproductivequality control but anadditional beneﬁt has
also been proposed (Blanks and Brosens, 2013). Repeated shedding of
the endometrium necessitates complete repair and regeneration of
the denuded surface. Therefore, events that would only otherwise
occur after parturition are repeated monthly. This may bestow upon
the human endometrium an extraordinary ability to adapt to optimize
function and would explain why most women suffering from recurrent
miscarriage eventually achieve a successful pregnancy (Blanks and
Brosens, 2013). Hence, there may be an evolutionary beneﬁt to men-
struation that explains its occurrence, and persistence, in women. So
what can we learn from this physiological process that has been so care-
fully preserved in women and what are the consequences when aberra-
tions occur?
Menstruation: a model of self-limiting
inﬂammation?
The menstrual endometrium displays the classic hallmarks of inﬂamma-
tion, including tissue oedema and inﬂux of immune cells. This inﬂamma-
tory process that occurs in the endometrium at menstruation is entirely
physiological and tightly regulated to prevent loss of function (Critchley
et al., 2001).Outwith the reproductive tract, this physiological inﬂamma-
tion does not occur. However, the ovary and endometrium display
repeated inﬂammation throughout a woman’s reproductive lifespan at
ovulation and menstruation, respectively (Rae and Hillier, 2005). Delin-
eationof the factors involvedand their regulationmay lead to therapeutic
beneﬁts for gynaecological conditions such as heavy menstrual bleeding
(HMB) and may be applicable to a host of inﬂammatory disorders at
other tissue sites.
What causes menstruation?
Progesteronewithdrawal. It is widely accepted that the sharp decline in cir-
culating progesterone levels due to corpus luteum demise is the trigger
for menstruation in women. Human studies using progesterone antago-
nists during the secretory phase have mimicked the events of menstru-
ation, providing proof that progesterone withdrawal is important in
menstrual physiology. Administration of mifepristone during the mid-
secretory phase has increased our knowledge of local endometrial
events during humanmenstruation, revealing an increase in endometrial
inﬂammatory mediators, such as cyclo-oxygenase (COX-2), nuclear
factor (NF)kB and interleukin (IL)-8 (also known as CXCL8) (Critchley
et al., 1999a, 2003). Studies in the rhesus macaque have conﬁrmed the
importance of progesteronewithdrawal in the inductionofmenstruation
(McClellan et al., 1984; Nayak et al., 2000). Menstruation was artiﬁcially
induced inmacaquesbysurgical removal of ovaries followedby14daysof
estrogen priming prior to insertion of a progesterone capsule to mimic
the secretory phase. Consistent with ﬁndings in women, removal of
the progesterone implant resulted in menstruation, evenwhen estradiol
exposure was maintained. This ﬁnding emphasizes the dominance of
progesterone withdrawal over estradiol withdrawal for menses induc-
tion. In contrast, when attempting to induce simulated menstruation in
the scientiﬁcally versatile murine model, progesterone withdrawal was
insufﬁcient for induction of bleeding (Finn and Pope, 1984; Brasted
et al., 2003; Menning et al., 2012; Rudolph et al., 2012; Cousins et al.,
2014). This problem was surmounted by an injection of arachis oil into
the uterine lumen when progesterone levels are high. This ‘induced
injury’ resulted in pre-implantation decidualization of the murine endo-
metrium, analogous to naturally occurring mid-secretory events in the
macaque and human. Hence, the murine model of simulated menstru-
ation reiterates the importance of decidualization prior to progesterone
withdrawal in menstrual physiology.
Further support for the key role of the decidualized endometrial
stromal cell in menstrual induction is derived from human in vivo and in
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vitro studies. Of note, the progesterone receptor (PR) has at least two
isoforms, PRAandPRB,which act as transcriptional regulatorsof proges-
terone responsive genes (Graham et al., 1995; Graham and Clarke,
1997).Although thebasal endometrial layer showspersistent PRexpres-
sion throughout the menstrual cycle, PR has differing temporal and loca-
tional expression in the functional layer (Lessey et al., 1988; Snijders et al.,
1992). PR is widely present during the proliferative phase, but there is a
signiﬁcant decline in glandular epithelial cells of the functional layer during
the secretory phase. In contrast, PR persists in the stromal compartment
of the functional layer throughout the secretory phase, particularly in the
perivascular region. Immunohistochemical analysis of human tissue
revealed that PRA is the predominant isoform during the secretory
phase, with PRB declining in both stromal and glandular cells in the
latter half of the cycle (Wang et al., 1998; Brosens et al., 1999; Mote
et al., 2001). Hence, endometrial stromal cells remain responsive to pro-
gesterone throughout the secretory phase. Gene microarray-based
studies have been reviewed in Dey et al. (2004) and showed that analysis
of mid-secretory uterine tissue, ex vivo progesterone/PR antagonist-
treated endometrium, treated in vitro decidualized stromal cells and
uterine tissue from PR-deﬁcient mice have identiﬁed a panel of proges-
terone responsive genes that may be important for implantation.
Hence the mid-secretory phase decidualized stromal cells retain PR ex-
pression and confer maximal progesterone responsiveness, priming the
endometrium to respond to progesterone withdrawal.
In 2001, Kelly et al. published the hypothesis that local endometrial
events following progesterone withdrawal occur in two phases (Kelly
et al., 2001). The initial phase involves an inﬂux of cytokines and prosta-
glandins (PG) to the endometrium that is dependent on an efﬁcient re-
sponse of the perivascular decidualized stromal cells to decreasing
levels of the anti-inﬂammatory hormone progesterone (Catalano et al.,
2007; Evans and Salamonsen, 2014). The second phase occurs as a con-
sequence of increased cytokine production and results in an inﬂux of leu-
kocytes to the endometrial environment, activation and release of
matrixmetalloproteinases (MMPs) and destruction of the extracellular
matrix (ECM). This lytic phase is thought to be independent of PR
actions. This hypothesis was supported by an elegant study in ovariecto-
mized macaques, where progesterone implants were removed as
normal at the end of the simulated cycle but replaced at staggered time-
points from 12 to 72 h after initial withdrawal (Slayden and Brenner,
2006).Replacementup to24 hafterwithdrawal preventedmenstruation
and prevented increases in endometrial MMP1, 2 and 3. Replacement
after 36 h had no effect onmenstruation and partially blockedMMPpro-
duction, with signiﬁcantly less endometrial MMP2 expression. More re-
cently, these ﬁndings have been replicated in the murine model of
simulated menstruation (Wang et al., 2013). These studies demonstrate
a temporal progesterone deprived threshold, over which menstruation
becomes inevitable.
Endometrial inﬂammation and leukocyte trafﬁc. Although progesterone
withdrawal has an undeniable role in the initiation of menstruation and
MMPs are widely accepted as the mediators of endometrial breakdown
(Marbaix et al., 1996), the intermediate mechanisms of menstruation
remain under investigation. Progesterone withdrawal regulates phase
one of menstruation, by up-regulating local cytokine presence (Hannan
et al., 2004; Jones et al., 2004). However, phase two occurs despite
progesterone replacement after the critical threshold suggesting subse-
quent, independent regulation. Further evidence for these downstream
regulatory factors comes from observational studies of MMP expression
in human endometrial tissue. MMPs have the ability to degrade all com-
ponents of the ECM and are up-regulated at the time of menstruation as
a result of progesteronewithdrawal (Marbaix et al., 1996; Vassilev et al.,
2005). However, MMP expression in the perimenstrual phase is limited
to the functional endometrial layer despite the global hormonal changes
and persistent PR expression in the basal layer, suggesting a more local
tissue site-speciﬁc regulation.
Genemicroarray analysis of endometrial tissue biopsies collected from
womenduring themid-secretoryphasewhencomparedwith those taken
following progesterone withdrawal has identiﬁed potential gene candi-
dates involved in the regulation of menstruation. These studies revealed
an increase in CXCL8 and cyclo-oxygenase (COX)-2 following proges-
terone withdrawal (Critchley et al., 1999a; Catalano et al., 2007). COX
is the rate-limiting enzyme in the synthesis of PG and is present in two iso-
forms. COX-1 is widely expressed in many tissues, whereas COX-2 is
highly inducible. PGE2 and F2a have important reproductive functions
(Critchley et al., 2006). Loss of EP2, a PGE2 receptor, resulted in impaired
ovulation and reduced litter size (Kennedy et al., 1999; Tilley et al., 1999).
Gene ablation of the FP receptor, the receptor for PGF2a, resulted in loss
of parturition (Sugimoto et al., 1997). Both PGE2 and PGF2a concentra-
tions are increased signiﬁcantly in the human during the window of im-
plantation in natural cycles and also in patients undergoing in vitro
fertilization (IVF) and ovum donation. Interestingly, this proﬁle is abro-
gated when the endometrium is refractory (Vilella et al., 2013).
In vitro studies of decidualized human stromal cells revealed that
steroid hormone withdrawal increased a host of inﬂammatory mediators,
including IL-6, CCL11, GM-CSF, CCL2, IL1-RA, CXCL10 and CXCL8,
and this response was mediated by NF-kB (Evans and Salamonsen,
2014). NF-kB increases the transcription of a wide variety genes,
including cytokines (IL-1, IL-6), chemokines (CXCL8, chemokine
ligand 2/CCL-2) and adhesion molecules (intercellular adhesion mol-
ecule 1/ICAM, vascular cell adhesion molecule 1/VCAM) (Kayisli et al.,
2004). Human endometrial biopsies have also been shown to express
components of the NF-kB pathway, with evidence for activation of
NF-kB during the perimenstrual phase (King et al., 2001). These ﬁndings
havebeen replicated in themousemenstrual-likemodel (Xuet al., 2013).
A recent study in the mouse model of simulated menstruation links
NF-kB and COX-2 in the menstrual process. Inhibition of the COX
enzymes or NF-kB at the time of progesterone withdrawal signiﬁcantly
decreased the amount of bleeding and endometrial breakdown in this
murine model (Xu et al., 2013). Furthermore, there was a signiﬁcant de-
crease in leukocyte inﬂux after both interventions. Chromatin immuno-
precipitation analysis revealed thatNFkB binds to theCOX-2 promoter,
providing a mechanism of NFkB-mediated COX-2 up-regulation and
subsequent inﬂammatory cell inﬂux at menstruation. Progesterone is
known to have inhibitory effects onNF-kB activity, mediated by increas-
ing IkB production or by competing with NF-kB for recognition sites on
relevant genes (Kelly et al., 2001). In this way, the steroid hormones
modulate the local endometrial inﬂammatory environment by suppres-
sing NF-kB activity until menstruation is required.
Following progesterone withdrawal, there is a dramatic rise in the
endometrial leukocyte population (Bonatz et al., 1992; Salamonsen and
Lathbury, 2000). Neutrophil numbers are negligible throughout most
of the cycle but increase perimenstrually to comprise 6–15% of the
total cell number (Salamonsen and Lathbury, 2000). As key mediators
of the inﬂammatory response, neutrophils respond to inﬂammation by
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migrating rapidly to the site of injury to contain and clear any noxious
stimuli. Circulating neutrophils have a lifespan of a few hours, but neutro-
phils residing in inﬂamed tissue can survive for days. This is due to
decreased neutrophil apoptosis induced by pro-inﬂammatorymediators
and hypoxia (Ward et al., 1999; Cross et al., 2006). The importance of
this neutrophil inﬂux at menstruation was shown in the mouse model,
where neutrophil depletion using the antibody RB6-8C5 affected endo-
metrial breakdown and markedly delayed endometrial repair (Kaitu’u-
Lino et al., 2007a). Neutrophils contain high levels of MMPs and have
the ability to activate resident MMPs to initiate endometrial breakdown
(Gaide Chevronnay et al., 2011). In contrast, chronic inﬂammation is
characterized by a persistent neutrophil response due to decreased
apoptosis (Serhan and Savill, 2005). This prolonged neutrophil response
results in tissue damage and loss of function. Therefore, tight regulation
of neutrophil inﬂux and apoptosis is required for normal menstruation. B
cell lymphoma 2 (bcl-2) is an apoptosis regulator protein that is
expressed in the human endometrium (Otsuki et al., 1994). Examination
of human endometrial tissue revealed the presence of bcl-2 during the
proliferative and early secretory phases with decreased levels in the
late secretory and menstrual phases. These decreased levels correlated
with the appearance of apoptotic cells in the perimenstrual phase. This
cyclic pattern suggests that ovarian hormones regulate bcl-2 levels in
the endometrium (Critchley et al., 1999b). In this way, progesterone
withdrawalmay increasebcl-2 to limit the lifespanof endometrial neutro-
phils at menstruation, preventing a chronic inﬂammatory response.
Macrophages also increase in number throughout the secretory phase
to reach maximal numbers perimenstrually, during the luteo-follicular
transition (Bonatz et al., 1992; Critchley et al., 1999a; Thiruchelvam
et al., 2013). The regulation of the endometrial macrophage remains
under investigation. Lacking PR, these cells may be recruited from the
circulation due to increased endometrial chemoattractant production
and/or may proliferate in situ (Guo et al., 2011; Davies et al., 2013b).
These cells produce cytokines and proteases and are involved in tissue
remodelling and debris removal. The classic M1 (pro-inﬂammatory)
and M2 (anti-inﬂammatory) phenotypes represent simpliﬁed extremes
of macrophage function. These complex cells have the ability to adapt
and respond to the tissue environment in which they reside (Gordon
andMartinez, 2010;Davies et al., 2013a). The phenotypeof endometrial
macrophages during the perimenstrual phase is yet to be fully delineated,
but considering their known functions they are likely to have a signiﬁcant
impact in the endometrium atmenstruation (Thiruchelvam et al., 2013).
Furthermore, delineation of macrophage phenotype in this physiological
model of tissue ‘injury’ and ‘repair’ may provide novel insights to patho-
logical conditions, such as chronic inﬂammation or cancer, where resi-
dent macrophages are involved in aberrant function (Laoui et al.,
2014). A direct comparison of the macrophage proﬁle throughout the
physiological inﬂammatory response of menstruation with the macro-
phage response in areas of chronic inﬂammationmay lead to novel thera-
peutic targets to improve tissue function.
Taken together, the studies described above support the hypothesis
that the decidualized stromal cell compartment can increase cytokine
and chemokineproduction to attract leukocytes, orencourage their pro-
liferation in the functional endometrial layer, during the perimenstrual
phase. For summary of perimenstrual leukocyte trafﬁc, see Fig. 2. In
turn, endometrial leukocytes produce MMPs and have the potential to
stimulate MMP production from adjacent cells (Jabbour et al., 2006)
making themattractive candidates for the regulation of local endometrial
MMP expression. In this way the decidualized stromal cells of the
functional layer help determine their own fate, limiting the inﬂammatory
reaction and tissue breakdown to the upper luminal portion of the endo-
metrium. This compartmentalization of inﬂammation, with sparing of
the basal layer, may be critical for efﬁcient repair of the endometrium
after shedding (menstruation). There is evidence that the amount
of endometrium that is shed during menstruation varies between
individuals, but it remains undetermined if the depth of shedding is asso-
ciated with gynaecological pathologies (Ludwig and Spornitz, 1991;
Fraser et al., 2001).
What limits endometrial inﬂammation?
An excessive or prolonged inﬂammatory response at menstruation will
lead to excessive tissue damage and may result in HMB (NICE, 2007).
Studies examining endometrial tissue fromwomenwith objectivemeas-
urementof theirmenstrual blood loss (MBL)have identiﬁed a signiﬁcantly
increased inﬂammatory response in women with HMB. Increased levels
of the pro-inﬂammatory cytokine tumour necrosis factor awere identi-
ﬁed in the menstrual efﬂuent of women with HMB (MBL. 80 ml) com-
pared with women with normal MBL (Malik et al., 2006). Endometrial
COX-2 mRNA expression was also signiﬁcantly elevated in women
with HMB (Smith et al., 2007). In addition, increased levels of total PGs
have been found in the endometrium of women with HMB (Smith
et al., 1981a, b). Furthermore, increased signalling of PGE2 through its
EP2 and EP4 receptors has been suggested due to elevated production
and decreased hydrolysis of cyclic AMP (Smith et al., 2007). In support
of these ﬁndings, PG synthesis inhibitors are a popular treatment for
HMB. Mefenamic acid is a non-steroidal anti-inﬂammatory compound
which signiﬁcantly decreases MBL (Cameron et al., 1990). However, al-
thoughwomen treatedwithmefenamic acid havea signiﬁcantdecrease in
theirmenstrual loss, 52%maintained ablood loss greater than80 ml after
2 months of treatment, highlighting the need for more effective medical
therapies for this condition (Cameron et al., 1990).
Glucocorticoids. The inﬂammatory response of physiological menstru-
ation appears to be self-limiting. The pro-inﬂammatory cytokine IL-1
has been shown to increase the expression of 11b hydroxysteroid
dehydrogenase-1 (11bHSD-1) (Rae et al., 2004; Rae and Hillier,
2005). This enzyme converts cortisone (compound E) to the anti-
inﬂammatory steroid cortisol (compound F). Glucocorticoids alter the
inﬂammatory response by limiting cytokine production, increasing
macrophage phagocytosis, increasing transcription of anti-inﬂammatory
genes and repressing pro-inﬂammatory transcription factors (Zhang
et al., 2009).
Endometrial 11bHSD-1 mRNA levels are signiﬁcantly increased at
menstruation, consistent with a role in endometrial breakdown and
repair (McDonald et al., 2006). In addition, the glucocorticoid receptor
is present throughout the cycle in the stromal compartment, including
endometrial leukocytes and endothelial cells (Bamberger et al., 2001;
Henderson et al., 2003). In this way, local generation of glucocorticoids
by inﬂammatory mediators may prevent an excessive inﬂammatory re-
sponse in the menstrual endometrium. Studies of endometrium from
women with HMB further highlight the importance of glucocorticoids
in endometrial physiology. Secretory endometrium from women with
a blood loss greater than 80 ml was found to have signiﬁcantly elevated
levels of 11bHSD-2 when compared with endometrium from women
with normal loss (Rae et al., 2009). 11bHSD-2 converts cortisol back
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to cortisone and may explain the excessive local inﬂammation of the
endometrium in women with HMB at menses. Decreased cortisol
levels and loss of its anti-inﬂammatory effects may prolongmenses, con-
tributing to heavy blood loss. We are currently exploring whether
‘rescue’ of putative luteal phase endometrial glucocorticoid deﬁciency
could reduce menstrual bleeding (Warner et al., 2015).
Control of the MMP response at menses.MMPs have the ability to degrade
all components of the ECMand have been shown to have an integral role
in endometrial breakdown at menses (Marbaix et al., 1996). Lack of
control of MMP action at menstruation will lead to excessive tissue
damage and may lead to abnormal bleeding. The control of MMP
action occurs at a number of levels to prevent an abnormal response
during menses and allow for tissue regeneration and remodelling at
other phases of the cycle. A full review of these processes is beyond
the scope of this review, and the reader is referred toGaideChevronnay
et al. (2011) for a comprehensive overview. It iswell established that pro-
gesterone inhibitsMMP transcription to suppress their expression during
the secretory phase of the cycle (Schatz et al., 1994; Salamonsen et al.,
1997; Vassilev et al., 2005). The withdrawal of progesterone and the
up-regulation of MMP levels during menstruation have been discussed
above. Following endometrial breakdown,MMP activity can be inhibited
by tissue inhibitors of metalloproteinases (TIMPS) or by the protease in-
hibitor a2-macroglobulin. These factors are expressed in the endomet-
rium throughout the menstrual cycle (Sayegh et al., 1995; Zhang and
Salamonsen, 1997) suggesting that they are overwhelmed by an increase
in MMP production at menstruation and that the ratio of MMPs to
TIMPsmaydictate the ability ofMMPs to breakdown tissue.Additionally,
active MMPs undergo endocytic clearance by low-density lipoprotein
receptor-related protein-1 (LRP-1) during the proliferative and secre-
tory phase of the cycle, initiating lysosomal degradation. At menstru-
ation, the LRP-1 protein is not present due to tissue shedding (Selvais
et al., 2009), enhancing MMP activity. This multifactorial regulation
limits the MMP response to menstruation, ensuring tissue damage is
not prolonged.
The endometrium: a model of vascular
function
Menstruation as a physiological ischaemia-reperfusion injury
The ﬁrst observations of endometrial architecture at menstruation were
from intraocular endometrial transplants in the rhesus macaque
(Markee, 1940). Direct observation of the explants following progester-
onewithdrawal revealed shrinkageof endometrial thickness, followedby
Figure 2 Leukocyte trafﬁcking in the perimenstrual human endometrium (derived from data published and reviews by Bonatz et al., 1992; Salamonsen
and Lathbury, 2000; Moffett-King, 2002; Thiruchelvam et al., 2013). Top panel: Sex steroid proﬁles in the luteo-follicular transition (perimenstrual
‘window’). Bottom panel: Overview of leukocyte trafﬁc in the endometrium with transition from secretory phase through menses/endometrial repair
to the proliferative phase of next cycle. Size of cell image reﬂects abundance.
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vasoconstrictionof spiral arterioles and focal bleeding. The vasoconstric-
tion observed was transient but intense, consistent with an ischaemia-
reperfusion injury. However, the presence and role of hypoxia in the
endometrium remain controversial.
Ischaemia has not been detected in the human endometrium during
menstruation to date. Laser Doppler ﬂuximetry measures the number
of red blood cells transiting a monitored volume per unit time. This
method failed to detect ischaemia during menstruation (Gannon et al.,
1997), but the limited spatial resolution of ﬂuximetry may not detect
focal or prolonged ischaemia-reperfusion episodes. There is some indir-
ect evidence that hypoxia occurs at menstruation in human endometrial
tissue. Markers of tissue hypoxia (CAIX and hypoxia inducible factor
(HIF)-1a) have been detected immunohistochemically in the human
endometrium at menses, with a distinct reduction in staining of both
markers after cycle day 5 (Critchley et al., 2006; Punyadeera et al.,
2006). In addition, hypoxia has beendetected in themenstrual endomet-
rium of the simulated mouse menstruation model (Fan et al., 2008).
Pimonidazole is a marker of oxygen partial pressures less than
10 mmHg, and its expression was seen in the uppermost endometrial
zones during the simulated menstrual phase. Negligible pimonidazole
levels were observed by Day 5 after progesterone withdrawal. In con-
trast, hypoxia, pimonidazole and HIF-1a were not detected following
ovarian hormonewithdrawal in a xenograftmensesmodel, where a frag-
ment of human endometrial functional layerwas grafted into immunode-
ﬁcient mice (Coudyzer et al., 2013). These differencesmay be explained
bydisturbanceof the full thickness endometrial architecture in the immu-
nodeﬁcient xenograftmodel,where spiral arteriole function and immune
cell function will be modiﬁed, but deﬁnitive proof that hypoxia is present
in the human endometrium at menses is still lacking.
Even if hypoxia is present in the endometrium, there remains debate
about its function. Primary human endometrial stromal cells cultured in
normoxic (21% O2) and hypoxic (2% O2) conditions for 24 and 48 h
revealed that hypoxia decreased the secretion of membrane-type 1
MMP, activeMMP-2, proMMP-1 and proMMP-3 (Zhang and Salamonsen,
2002). Similar decreases in MMPs were also observed in the culture
supernatants from whole endometrial explants cultured in 0.1% O2 for
24 h (Gaide Chevronnay et al., 2010). This suggests that hypoxia is not
involved in endometrial breakdown by MMPs at menstruation, but
does not exclude a role in repair of the denuded surface and limitation
of the MMP response. In the xenograft model described previously,
increases in MMP expression were observed in the human endometrial
grafts and breakdown occurred within 96 h of ovarian hormone with-
drawal. In addition, the xenografted endometrium underwent complete
repair despite the absence of hypoxia. This suggests that hypoxia is not
essential for endometrial breakdown or repair. However, in vivo
human menstruation occurs 48–72 h after withdrawal of ovarian hor-
mones (Catalano et al., 2007) and the mouse model of menstruation
demonstrates bleeding within 8–12 h of hormone withdrawal (Brasted
et al., 2003; Menning et al., 2012; Cousins et al., 2014). Hence 8 h post-
progesterone withdrawal in the murine model is approximately equiva-
lent to 48 h in the human. Therefore, it remains possible that, although
hypoxia is not necessary for endometrial breakdown and repair, it is de-
sirable for maximal efﬁciency of these processes. HIF-1 is a transcription
factor known to be the master regulator of the cellular response to
hypoxia (Iyer et al., 1998). In hypoxic conditions, this factor increases
the transcription of a numberof genes involved in angiogenesis,mitogen-
esis and metabolism. Its prolonged activation is observed in the tumour
microenvironment, leading to aberrant angiogenesis and metastasis
(Mazzone, 2010). However, transient activation appears necessary in
physiological situations to instigate repair processes. For example,
pharmacological activation of HIF-1 provided protection against devel-
opment of colitis in a murine model (Cummins et al., 2008). The role
of HIF-1 in menstruation, if any, remains to be determined.
Vasoconstriction
Regardless of the presence or absence of hypoxia in themenstrual endo-
metrium, vasoconstriction of spiral arterioles is desirable at this time to
limit blood ﬂow. Poiseuille’s equation states that the radius of a vessel is
the major determinant of resistance to ﬂow, meaning that a small in-
crease in vessel radius will dramatically increase the amount of blood
ﬂowing through it (Maybin et al., 2011a). Therefore, decreased constric-
tion of endometrial vessels at the time of menstruation will contribute
signiﬁcantly to increased menstrual blood loss. PGF2a and endothelin-1
(ET-1) are twoendometrial factorswith known vasoconstrictiveproper-
ties (Baird et al., 1996; Marsh et al., 1997). In contrast, PGE2 is a known
vasorelaxant.Womenwith heavyMBLhavebeen shown tohave a signiﬁ-
cantly decreased PGF2a/PGE2 ratio (Smith et al., 1981b) and decreased
FP receptor expression (Smith et al., 2007). Excessive PGE2 production
at the expense of PGF2a may result in less constriction of the spiral
arterioles prior to menstruation. In addition, women with HMB have
decreased endometrial expression of the potent vasoconstrictor ET-1
and increasedexpressionof itsmetabolising enzyme, neural endopeptid-
ase (Marsh et al., 1997). Increased metabolism of endothelin could
explain its decreased endometrial expression and cause dilation of endo-
metrial vessels at menstruation. Furthermore, altered spiral arteriole
maturation may also contribute to inefﬁcient spiral arteriole vasocon-
striction atmenstruation.Vesselwall circumference and focal discontinu-
ities were noted to be larger in the endometrium of women with HMB
than normal controls (Mints et al., 2007). Women with heavy bleeding
had signiﬁcantly reduced vascular smooth muscle cell proliferation in
spiral arterioles during the mid-late secretory phase when compared
with normal controls (Abberton et al., 1999b). In addition, smooth
musclemyosin heavy chain, a contractile protein used as amarkerof vas-
cular smoothmuscle cell maturation, was signiﬁcantly decreased in spiral
arterioles ofwomenwithHMB (Abberton et al., 1999a). The endothelial
cell lining in endometrial tissue fromwomenwithHMBwas found tohave
increased gaps, possibly due to increased expression of angiopoietin-2
during the secretory phase (Mints et al., 2010). This suggests that
vessels in these women are pre-programmed during the proceeding
cycle to be more fragile at menstruation. Taken together, the decreased
levelsof vasoconstrictive factors and immaturevesselspresent inwomen
with HMB will signiﬁcantly increase MBL.
The endometrial coagulation system
Cessation of menstruation relies on an intact endometrial coagulation
system to achieve haemostasis (Fig. 3). Endometrial endothelial injury
initiates immediate activation and aggregation of platelets to form a
plug. This takes place by two mechanisms (i) platelet glycoprotein inter-
actionwith vonWillebrand factor (vWF)or (ii) tissue factor generationof
thrombin (Davies and Kadir, 2012). The resulting platelet plug forms a
barrier toprevent further blood loss. The subsequent stageof haemosta-
sis involves the formation of ﬁbrin via the coagulation cascade. The co-
agulation cascade is activated by two pathways; extrinsic and intrinsic.
Each culminates in the conversion of factor X to Xa, which catalyses
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the conversion of pro-thrombin to thrombin, ultimately leading to the
formation of a more stable ﬁbrin clot to seal previously bleeding
vessels. Disorders that interfere with systemic haemostasis have an
impact on MBL. Von Willebrand disease is the most common of these
disorders, with a prevalence of 13% in women with a complaint of
HMB (Shankar et al., 2004).
Fibrinolysis involves conversion of plasminogen to active plasmin, pro-
moting the degradation of ﬁbrin deposits. Tissue plasminogen activator
(t-PA) and urokinase plasminogen activator (u-PA) drive the production
of plasmin. In contrast, plasminogen activator inhibitor (PAI) inhibits ﬁ-
brinolytic activity. The human endometrium contains t-PA and u-PA, as
well as PAI and the uPA receptor (Gleeson et al., 1993; Nordengren
et al., 2004). There is evidence that an overactive ﬁbrinolytic system inter-
feres with haemostasis and contributes to HMB. Women with HMB had
raised levels of t-PA activity on the second day of bleeding compared
with those with normal loss (Gleeson et al., 1993). The efﬁcacy of tranex-
amic acid as a treatment for HMB provides further evidence for over acti-
vation of the ﬁbrinolytic system in the endometriumof thesewomen. This
antiﬁbrinolytic reduces t-PAandPAI levels inwomenwithHMBandresults
in a 58% reduction in blood loss (Gleeson et al., 1994).
Angiogenesis
Vascularmodiﬁcation andnewblood vessel growth areessential compo-
nents of endometrial physiology. Atmenstruation, rapid repair of injured
blood vessels must occur to stop bleeding, and this is usually completed
by Day 5 of the cycle. This process occurs despite lack of ovarian
hormone support, as observed inwomen following surgical ovariectomy
who stop bleeding despite the lack of ovarian hormonal support. In add-
ition, themurinemodel ofmenstruationdisplayed complete repairof the
endometrium in the absenceof estradiol (Kaitu’u-Lino et al., 2007b), sug-
gesting vascular repair at menses (in this animal model) is not reliant on
estrogen. The regulation of vascular repair at this stage is still to be fully
delineated. Vascular endothelial growth factor (VEGF), a key mediator
of vascular function, is increased in women at menses, and there is
mounting evidence from human and murine studies that endometrial
VEGF is regulated by hypoxia (Charnock-Jones et al., 1993; Sharkey
et al., 2000; Fan et al., 2008; Maybin et al., 2011b).
During the proliferative phase, there is rapid growth of the functional
layer of the endometrium, necessitating angiogenesis to maintain perfu-
sion of new tissue (Girling and Rogers, 2005). This physiological angio-
genic response is unusual in the human adult and provides an
accessible human model for comparison to pathological situations such
as the tumour microenvironment. Therefore, deﬁning the control and
mechanisms of this normal angiogenesis may identify new approaches
to the control of tumour growth.Despite the signiﬁcant changes in endo-
metrial architecture across the cycle, it has been repeatedly demon-
strated that levels of endothelial cell proliferation within the human
endometrium do not show any consistent pattern across the menstrual
Figure 3 Endometrial coagulation pathways. Immediate: A platelet plug forms rapidly, relying on interactions with tissue factor, vWF and collagen. Sub-
sequent: intrinsic and/or extrinsic activation of coagulation pathways result in formation of a ﬁbrin clot to ensure haemostasis. Fibrinolysis drives the deg-
radation of the ﬁbrin clot. t-PA and u-PA convert plasminogen to plasmin, which breaks down the ﬁbrin clot. PAI converts plasmin back to plasminogen.
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cycle (Girling andRogers, 2005). Interpretationof these results is challen-
ging, as samples taken from women at the same stage of the menstrual
cycle are extremely variable. This may be due to differences in
hormone levels at the time of sampling or a variation in the region
from which the biopsy was obtained. To overcome this, Nayak and
Brenner utilized the macaque simulated menses model (Nayak and
Brenner, 2002). Using Ki67 or bromodeoxyuridine (BrdU) to identify
proliferating endothelial cells, the authors demonstrated a 6-fold in-
crease in proliferation during the mid-proliferative stage (Days 8–10
after progesterone withdrawal). This peak was absent in the hormone-
deprived animals, indicating endothelial cell proliferation at this stage in
the cycle is estradiol dependent, unlike the vascular response at
menses. No signiﬁcant changes in proliferation were observed at other
stages of this artiﬁcial cycle. This ﬁnding concurs with stereological ana-
lysis of human endometrial endothelial cell staining, where vascular
length density was greatest during the mid-late proliferative phase
(Gambino et al., 2002). By examining vessel length and branch points,
the authors concluded that vessel elongation is the major mechanism
by which endometrial angiogenesis occurs in mid-proliferative phase.
In the secretory phase, coiling and maturation of the spiral arterioles
and growthof the subepithelial capillary plexusmust takeplace.The con-
sequence of impaired vascularmaturation during this phase has been dis-
cussed above in regard to decreased vasoconstriction and its relation to
HMB. It is likely that the uterine natural killer (uNK) cells play an import-
ant role in spiral arteriole maturation.
Uterine NK cells are CD56bright, CD16-, CD3- and are phenotypically
different fromperipheral bloodNKcells (Koopman et al., 2003). uNKcells
increase in number during the mid-luteal phase and are located close to
the endometrial glands and spiral arteries (Dosiou and Giudice, 2005),
supporting a role in vascular remodelling. Evidence derived from early
pregnancy studies supports a role for uNK cells in the early stages of
spiral arteryremodelling,where failureof thisprocess is consideredtocon-
tribute to pregnancy pathology (Moffett-King, 2002; Robson et al., 2012).
The lack of spiral arteriole modiﬁcation observed inmice deﬁcient in uNK
cells further supports this hypothesis (Greenwood et al., 2000; Ashkar
et al., 2003).
Additional evidence for the impact of uNKcells on endometrial vascu-
lature comes from studies of the action of selective progesterone recep-
tor modulators (SPRMs) in the human endometrium. Analysis of
endometrium from women administered the SPRM asoprisnil revealed
a suppressed IL-15 pathway, which regulates uNK development and
function. There was a marked reduction in uNK cells, an abnormal
appearance of endometrial vasculature with increased a-SMA staining
surrounding the spiral arterioles. Women taking this SPRM had signiﬁ-
cantly decreased menstrual bleeding, linking the PR, uNK cells, vascular
structure and menstrual function (Wilkens et al., 2013). The inability to
identify the PRon uNKcells (Henderson et al., 2003) suggests an indirect
mechanism of hormonal regulation, via paracrinemediators such as che-
mokines (Salamonsen and Lathbury, 2000; Hannan and Salamonsen,
2007).
The importanceof vascular normalization has recently becomeappar-
ent in the ﬁeld of cancer biology. Blockade of VEGF to prevent angiogen-
esis in the tumour microenvironment was logically introduced as a
treatment for cancer (Carmeliet, 2005). Although initial results were en-
couraging, themean survival of patients treatedwith these inhibitors dis-
appointingly remained unchanged (Carmeliet and Jain, 2011). Recent
research has highlighted the beneﬁts of vessel normalization, rather
than inhibition of angiogenesis, as a mechanism to reduce metastasis
and hopefully increase survival (Mazzone et al., 2009; Carmeliet and
Jain, 2011). Therefore, delineation of normal vascular processes and
their regulation within the human endometrium, including physiological
angiogenesis and vessel maturation, could have widespread clinical
application.
The perimenstrual endometrium: a model of
scarless tissue repair
After shedding its luminal portion, the endometrium must efﬁciently
repair to ensure implantation can take place if fertilization occurs in the
subsequent cycle. The processes involved in endometrial repair
appear to be analogous to classic wound healing and include inﬂamma-
tion, its resolution, angiogenesis, tissue formation and tissue remodelling.
The ﬁrst three processes havebeendiscussed above, and this sectionwill
concentrate on the latter two, with discussion of the former where ne-
cessary. The cross disciplinary beneﬁts of studying this scar-free repair
system are obvious, but incisive data on the factors involved and their
regulation remain elusive and concerted efforts are necessary to maxi-
mize the translational beneﬁts.
The regulation of endometrial repair and regeneration
Scanning electronmicroscopy of humanmenstrual endometrial samples
revealed a ragged and torn surface with gland openings and a lack of epi-
thelial covering (Ludwig andSpornitz, 1991). Subsequent regrowthof the
epithelium occurred before stromal expansion, with epithelial cells
growing from the necks of the glands to meet migrating cells from
other glands, forming a new luminal surface. This began on menstrual
Day 2, and full coverage of the lumen was achieved by Day 6. A more
recent study found that the functional endometrial layer displays simul-
taneous shedding and repair in a piecemeal fashion during menstruation
(Garry et al., 2009). Both of these studies suggest that initial re-
epithelialization of the endometrium occurs during active bleeding in
the absence of ovarian hormones, consistent with ﬁndings in the murine
menstruation-like model (Kaitu’u-Lino et al., 2007b) and in women
post-oophorectomy.
Tissue recombination studies in themousemodel suggest that uterine
epithelialization is required before the stromal compartment can
respond to ovarian steroids (Bigsby, 2002). Stromal cell mitoses ﬁrst
appear on Days 5–6 of the human menstrual cycle, when estradiol
levels are rising and the epithelial layer has completely healed (Ferenczy
et al., 1979).Unlike the initial repair phase, this endometrial regeneration
is dependent on ovarian hormone support. VEGF, a potent mitogenic
and angiogenic factor, was found to have three peaks of expression in
the ovariectomized macaque model of menstruation (Nayak and
Brenner, 2002). These increases in VEGF mRNA occurred in the
surface epithelium during the early proliferative phase, in the stroma
during themid-proliferative phase and in the glands during the late secre-
tory phase. Comparison of hormone-deprived and estrogen-exposed
animals revealed that estrogen is not essential for the early proliferative
phase peak but is necessary for VEGF mRNA up-regulation in mid-
proliferative stromal cells. These ﬁndings support an estrogen-
independent initial repair phase and estrogen-dependent regeneration
of the endometrium.
Hence alongside initiation of menstruation, progesterone withdrawal
is also likely to trigger endometrial repair. Support for this hypothesis is
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found in gene microarray analysis of differentially expressed transcripts
from human endometrial explants cultured in vitro in the presence of
ovarian hormones or in the absence of hormonal support. This
hormone deprivation model revealed ‘wound healing and inﬂammation’
as a top scoring biological process (Gaide Chevronnay et al., 2010). The
importance of VEGF for luminal re-epithelialization and angiogenesis at
menstruation was demonstrated using VEGF Trap in the macaque and
murine models (Fan et al., 2008). Progesterone withdrawal has been
shown to increase the expression of VEGF in the macaque model
(Nayak and Brenner, 2002), murine model (Fan et al., 2008) and in
human endometrial explants (Maybin et al., 2011b). Hypoxia and PGs
have been associated with these increases in VEGF expression (Fan
et al., 2008; Maybin et al., 2011b) and may represent downstreammed-
iators of progesterone withdrawal.
The importance of the vascular niche in tissue regeneration is further
supported by studies of stromal-derived growth factor (SDF-1) and its
receptors CXCL4 and CXCL7. SDF-1 is present throughout the men-
strual cycle and CXCR4 expression peaks in the early proliferative
phase and is present in epithelial cells and endothelial cells (Laird et al.,
2011). SDF has been shown to increase endometrial epithelial cell pro-
liferation in vitro (Tsutsumi et al., 2011). A recent study combining an in-
ducible endothelial-cell-speciﬁc mouse gene deletion strategy and
complementarymodels of acute and chronic liver injury revealed thatdif-
ferential recruitment of pro-ﬁbrotic CXCR4 or pro-regenerative
CXCR7 signalling determines if the liver regenerates or becomes ﬁbrotic
after injury.Hence, autocrine signals fromtheendotheliummay inﬂuence
the rate and nature of the repair process. The role and regulation of
CXCR4andCXCR7 in thenormalmenstrual endometrium,where scar-
ring is absent, and in the rare syndrome of endometrial scarring, Asher-
man’s, remains to be determined.
The cellular andmolecularmechanisms governing epithelial cell prolif-
eration and migration after menstruation have not been fully elucidated.
At least three hypothesized mechanisms exist, including (i) proliferation
of luminal epithelial cells from the base of the epithelial glands, (ii) mes-
enchymal to epithelial transition of residual stromal cells and (iii) regen-
eration of the luminal epithelium from endometrial stem cells.
Mesenchymal-to-epithelial transition
Previously, the ‘free-edge’ effectwas thought to be responsible for endo-
metrial re-epithelialization, where the absence of neighbouring cells at
the wound margin acts as a growth signal (Heimark and Schwartz,
1985). However, scanning electron microscopy of menstrual endomet-
rium revealed that epithelial cells appeared to arise from underlying
stromal cells in denuded portions, rather than solely from the necks of
epithelial glands (Ludwig and Spornitz, 1991;Garryet al., 2009). This sug-
gests that endometrial stromal cells are reprogrammed at menstruation
to lose their mesenchymal cell characteristics and gain epithelial cell
traits, a process known as mesenchymal-to-epithelial transition (MET).
Evidence for MET during endometrial repair comes from the murine
model of simulated menses, where co-expression of the epithelial
marker pancytokeratin and the stromal cell marker vimentin occurred
in endometrial cells after 24 h of hormone withdrawal (Patterson et al.,
2013). Gene microarray analysis of murine uterine tissue from the simu-
lated menses model taken pre- and post-progesterone withdrawal
revealed signiﬁcant changes in genes known to be involved in MET
such as cytokeratin, Wnt1, E-cadherin and osteopontin (Cousins et al.,
2014). This study also identiﬁed actively proliferating cells in the
stromal compartment, where there was loss of luminal epithelial cover-
age and proliferation of adjacent luminal epithelial cells, consistent with
simultaneous MET and epithelial cell migration. In this way, the residual
basal layer of the endometrium and the adjacent unshed functional
layer can contribute to re-epithelialization of the denuded surface. The
contribution of the functional endometrial layer to menstrual repair is
supported by microarray study of stromal and glandular cells from the
basal and functional layer obtained by laser capture microdissection
(Gaide Chevronnay et al., 2009). This revealed that in addition to
up-regulation of transcripts involved in tissue degeneration, stromal
cells from the functional layer also displayed increased levels of genes
associated with ECM biosynthesis, indicating an important contribution
to repair of adjacent denuded areas.
The reverse process of epithelial-to-mesenchymal transition (EMT) is
also important forwound healing, embryogenesis and ﬁbrosis (Gonzalez
and Medici, 2014). The loss of adhesion molecules and tight junctions
alongside increased expression of mesenchymal cell markers allows mi-
gration into tissues. In the embryo, cycles of EMTandMET are necessary
for development andhighlight the reversibility of these processes (Nieto,
2013). The role of EMT, if any, in the endometrium remains to be deter-
mined, but it is likely that a balance of EMT and MET is important for
repair processes. Excessive EMT has been implicated in ﬁbrotic diseases
of the kidney and lung (Kothari et al., 2014). This may be due to the gen-
eration of extreme myoﬁbroblasts that are resistant to apoptosis. Syn-
thesis and remodelling of the ECM by ﬁbroblasts is essential for wound
healing. Fibroblasts differentiate into myoﬁbroblasts during the last
phases of wound healing and increase their expression of smooth
muscle actin (SMA). These myoﬁbroblasts initiate wound contraction
and secrete type I collagen. Persistence of myoﬁbroblasts at an injury
site results in scar formation (Hantash et al., 2008). Therefore, excessive
EMT may induce scaring via aberrant myoﬁbroblast differentiation
causing persistence at the injury site. Cytokines, hypoxia, growth
factors and components of the ECMhave all been implicated in the regu-
lationof EMT (Gonzalez andMedici, 2014). Strict control of these factors
in the human endometrium may therefore underpin its exceptional
ability to heal without scarring. Interestingly, normal human endometrial
stromal cells have signiﬁcantly less a-SMA expression and contractility
when compared with endometriotic stromal cells (Yuge et al., 2007).
This suggests endometrial cells have less myoﬁbroblastic differentiation,
leading to a reduction in scar formation. In this way, the balance of MET
and EMTmay inﬂuence endometrial repair atmenstruation. Aberrations
in their control could lead to pathology such as endometriosis, with its
associated adhesions and scarring, or delayed endometrial repair and
its consequent increased MBL.
Stem cells
Analternative, or perhaps complimentary,methodof endometrial repair
is regeneration of tissue from stem cells or progenitor cells. Evidence of
their existence in the endometrium comes from colony-forming units
derived from human endometrial samples (Gargett et al., 2009). These
cells fulﬁlled the criteria of self-renewal, high proliferative potential and
multilineage differentiation. In addition, the mouse model of simulated
menstruation suggests that re-epithelialization of the uterine surface
arises from progenitor cells residing in the glandular epithelial cells
(Kaitu’u-Lino et al., 2010). Unlike human studies, it is possible to utilize
the label retaining technique in the murine model, identifying stem cells
due to their relative quiescence and comparatively slower proliferation
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than more differentiated cells. A pulse of BrdU is followed by a chase
period,when slowly cycling cells retain the BrdU label and transient amp-
lifying cells proliferate rapidly and dilute the label. Examination of BrdU
and proliferating cell nuclear antigen immunoﬂuorescence in this
model revealed that glandular cells proliferated selectively during
repair and BrdU labelling remained constant. In contrast, luminal cells
showed rapid dilution of BrdU at menstruation. Both epithelial and
stromal label retaining cells have been identiﬁed in this mouse model
(Chan and Gargett, 2006).
For a comprehensive review of the contribution, derivation and appli-
cation of endometrial stem cells, we refer the reader to a number of
papers (Gargett and Masuda, 2010; Cervello et al., 2011, 2013; Deane
et al., 2013). Many questions remain, but it is clear that the multipotent
potential of cells within the endometrium can havewidespread beneﬁts.
Endometrial biopsies are obtainable in an outpatient setting, usually
without the need for anaesthetic. This is in contrast to the painful bone
marrow biopsy used to obtain haematopoietic stem cells. Mesenchymal
stem cells obtained from the endometrium are highly proliferative
(Gargett et al., 2009) and are therefore attractive for in vitro expansion
and use in cell-based therapies. Furthermore, multipotent cells have
also been derived from menstrual efﬂuent, negating the need for any
biopsy (Ulrich et al., 2013). Increased understanding and utilization of
these unique endometrial cells will beneﬁt many gynaecological condi-
tions. Endometriosis is caused by implantation and growth of endomet-
rial deposits in other tissue sites and is thought to occur secondary to
retrograde menstruation. However, although retrograde menstruation
occurs in many women, only 10% have evidence of endometrial
deposits (Gargett et al., 2014). The prevalence or activity of endometrial
stem cells in the endometrial fragments spilling into the abdominal cavity
may explain this discrepancy. An insufﬁciently thick endometrium can
contribute to sub-fertility and failed IVF. Endometrial stem cell therapy
is a potential treatment to regenerate the endometriumand increase fer-
tility rates in the future (Cervello et al., 2013). In addition, menstrual
derived cells have displayed regenerative properties at other tissue
sites. They have incorporated into atrophied skeletal muscle ﬁbres in a
mouse model of Duchenne muscular dystrophy and have resulted in
improved cardiac tissue function in an infarction model (Cui et al.,
2007; Toyoda et al., 2007; Hida et al., 2008). Endometrial cells have dif-
ferentiated into morphologically and functionally glucose-responsive
insulin secreting cells, providing a potential therapeutic strategy for dia-
betes (Santamaria et al., 2011). Therefore, accessible multipotent cells
from the endometrium could havewidespread and signiﬁcant future clin-
ical applications.
Conclusions
Many advances have beenmade to increase our knowledge ofmenstrual
physiology. However, why women menstruate and what starts, limits
and stopsmenstrual blood loss remain key questions. The endometrium
functions as acomplexmulticellular structure that involves interactionsof
immune, endocrine and vascular systems. The strict regulation of this
tissue to allow cyclical ‘injury’ and ‘repair’ at menstruation results in a re-
markable physiological response that allows pregnancy to occur. This ac-
cessible tissue, alongside robust animal models, provides a fantastic
resource in which to study inﬂammation, angiogenesis and tissue repair
(Fig. 1) to identify new therapeutic targets for gynaecological conditions
and generate translational knowledge for application at a host of other
tissue sites.
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